Related Experiment Video
Updated: May 25, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
[Revascularization of the hibernated myocardium: a clinical problem still unsolved]
Enrico Ammirati1, Valentina Guida, Ornella E Rimoldi
1Dipartimento Cardio-Toraco-Vascolare, Universitta Vita-Salute e Istituto Scientifico, San Raffaele, Milano.
Insights
Identifying hibernating myocardium is key for revascularization success in heart failure patients. This review examines evidence and proposes future trials for improving outcomes in ischemic left ventricular dysfunction.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Imaging
Context:
- Chronic left ventricular systolic dysfunction in coronary artery disease presents uncertain outcomes after revascularization.
- Identifying viable but dysfunctional myocardium (hibernating myocardium) is crucial for predicting recovery.
- Advances in medical therapy and devices have improved prognosis for heart failure patients.
Purpose:
- To review pathophysiological mechanisms, clinical studies, and meta-analyses on revascularization for ischemic left ventricular dysfunction.
- To discuss the role of hibernating myocardium in predicting functional recovery post-revascularization.
- To propose a future randomized trial assessing revascularization's prognostic impact on hibernating myocardium.
Summary:
- The mid- to long-term outcomes of revascularization in patients with chronic left ventricular systolic dysfunction due to coronary artery disease remain uncertain.
- Hibernating myocardium, identified by advanced imaging, can predict functional recovery after revascularization.
- The STICH trial assessed revascularization's prognostic benefit in addition to optimal medical therapy for ischemic left ventricular dysfunction.
Impact:
- Understanding hibernating myocardium aids in selecting appropriate patients for revascularization, potentially improving functional recovery.
- This review synthesizes four decades of research, informing clinical decision-making and future research directions.
- A proposed trial aims to definitively assess the prognostic value of revascularizing hibernating myocardium.
Abstract:
The mid- and long-term outcome of revascularization procedures is still uncertain in patients with chronic left ventricular systolic dysfunction due to coronary artery disease. The identification of dysfunctional myocardial segments with residual viability that can improve after revascularization is pivotal for further patient management. Hibernating myocardium (chronically dysfunctional but still viable tissue) can be identified by positron emission tomography and cardiac magnetic resonance and its presence and extent can predict functional recovery after revascularization. Before beta-blockers were introduced as routine care for heart failure, surgical revascularization appeared to improve survival in these patients. Nowadays, novel medical treatments and devices such as cardiac resynchronization therapy and implantable cardioverter-defibrillators have improved prognosis of these patients and their use is supported by a number of clinical trials. A recently concluded randomized trial, the STICH (Surgical Treatment for Ischemic Heart Failure) trial, has assessed the prognostic benefit derived from revascularization added to optimal medical therapy in patients with ischemic left ventricular dysfunction. This is an overview of the pathophysiological mechanisms as well as the main clinical studies and meta-analyses that have addressed this issue in the past four decades. Furthermore, a brief proposal for a randomized trial to assess effect on prognosis of revascularization of hibernating myocardium will be presented.
More Related Videos
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies